WinstonWınston
Back
Dr. Martens logo

Dr. Martens

DOCS.L
58
Apparel - Footwear & Accessories · Consumer Cyclical
Price
81.80 GBp
+2.90 (+3.68%)
Market Cap
£782.9M
Exchange
London Stock Exchange
Winston Score
58
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Mar 31, 2026
How the score breaks down
Quality
Good
Growth
Mixed
Cash Flow
Exceptional
Stability
Good
Valuation
Good
Dividends
Mixed

Share count falling — buybacks

2.3% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 1.00B (2022) → 979.6M (2026)

Winston Score History

The full picture

Dr. Martens is a British footwear company best known for its iconic lace-up boots with thick, air-cushioned soles. The brand has been around since 1960 and sells shoes, boots, and sandals to consumers around the world, particularly younger adults who are drawn to its distinctive style. It is one of the most recognizable boot brands globally, with the classic 1460 boot being its signature product.

The company makes money by selling footwear through its own retail stores, its website, and third-party retailers like department stores and independent shoe shops. Dr. Martens operates across the Americas, Europe, and Asia-Pacific, with the UK and US being its largest markets. The brand's strong cultural identity and loyal customer base give it some pricing power, but the company has faced falling sales and profitability pressure in recent years as consumer spending on discretionary items has weakened, making a recovery in demand its key near-term challenge.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
59.1%
Premium pricing power — 59.1% gross margin
Profit after running costs
Operating Margin
16.6%
Healthy — 16.6% operating margin
Return on the money invested
ROCE
12.5%
Good — 12.5% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-2.9%
Shrinking sales (-2.9% YoY)
Profit growth
EPS YoY
+479.1%
Earnings growing fast (+479.1% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
527%
Turns 527% of profit into real cash
Spare cash per sale
FCF Margin
15.2%
Converts sales into free cash efficiently (15.2%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.69
Moderate — manageable debt (0.69)
Covers its interest
Interest Cover
2.77x
Tight — interest eats into profit (2.8x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
32.9x
Pricey — P/E 32.9

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year
P/E vs Forward
+21.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (32.9 → 11.4)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
3.12%
Moderate income — 3.12% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record
Dividend Growth
-39.2%
Dividend cut (-39.2% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial